2025 Predictions: Industry Leaders Weigh in on the Future of OSD

February 17, 2025

Remove from favorites

Add to favorites

The article, authored by Karen Langhauser and published on Tablets & Capsules Magazine, discusses predictions for the future of oral solid dose (OSD) forms in 2025, highlighting several key trends:

- Patient-Centric Designs: There will be a continued focus on creating user-friendly dosage forms that improve adherence. This includes innovations like sprinkle formulations and orally disintegrating tablets, which cater to diverse patient populations, including pediatric and geriatric groups

- Technological Advancements: Technology will play a significant role, with advancements in automation, continuous manufacturing, and 3D printing. These technologies will help manufacturers respond to shifting patient demographics and needs, offering more personalized and efficient solutions

- Quality and Efficiency: Manufacturers will prioritize equipment efficiency and accuracy to stay competitive and manage costs. Addressing issues like nitrosamine impurities will remain crucial

- Nutraceuticals and Pharma-Level Accountability: The nutraceutical sector will face increased accountability and requirements similar to the pharmaceutical industry. Innovations in oral biologics will also aim to overcome bioavailability challenges, potentially expanding the market for weight-loss treatments

Overall, the future of OSD is set to be patient-focused and technologically sophisticated, with a strong emphasis on improving patient outcomes and manufacturing efficiency